Partner Content Partner Content SMi’s release speaker interview Anita Burrell, speaker at Bi... Biosimilars USA conference information
Partner Content Partner Content FDA releases Biosimilar Action Plan: Hear more at Biosimilar... Biosimilars USA conference information
Partner Content Partner Content SMi’s Biosimilars & Biobetters - Exclusive Interview with Dr... Biosimilars & Biobetters conference information
Events Partner Content SMi's 9th annual Biosimilars & Biobetters Biosimilars & Biobetters conference information
Partner Content Partner Content Agenda Released for USA Biosimilars Conference this November Agenda Released for USA Biosimilars Conference this Nov
Partner Content Partner Content Industry experts set to transform evolving pre-approval & un... Created in response to unprecedented global demand from patients and physicians and to provide a long-sought after alternative for the biopharma
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
